Loading
Life sciences · Interventional Study
ClinicalTrials.gov · November 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07910591). This is a study registration, not published results. Lead sponsor: University of Pittsburgh. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 200 participants (ESTIMATED). Conditions: Pediatric Sepsis. Interventions: DIETARY_SUPPLEMENT: For group Peds Sep A: Standard nutrition will be given; DIETARY_SUPPLEMENT: For Group Peds SepB: Low leucine, isoleucine formula; DIETARY_SUPPLEMENT: For Group Peds Sep C: Medium chain triglyceride oil enriched formula.; DIETARY_SUPPLEMENT: For Group Peds Sep D: Low carbohydrate ketogenic formula. Primary outcome measures: Organ failure free days. , Subjects will be monitored for 28 days or until PICU discharge. Brief summary: Children with sepsis, a condition in which infection causes organ dysfunction will be enrolled with parental permission in this study. Nutrition will be given according to their individual metabolic profiles until normalization of metabolism. Metabolism is the way that children process food to meet our body's needs, based on metabolic testing the children may need more or less carbohydrates, more or less fats or more or less protein. The investigators will measure whether normalization of metabolism with this personalized nutrition leads to resolution of organ dysfunction.